Burcon NutraScience annual return on equity
2021
2022
2023
2024
2025
2026
Burcon NutraScience Return on Equity (ROE) Growth & History (BRCNF)
Burcon NutraScience's return on equity was −2,488.94% for fiscal 2026.
View full Burcon NutraScience company overviewBurcon NutraScience annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −2,488.94% | −2352.30 pp |
| 2025 | 2025-03-31 | −136.64% | +23.65 pp |
| 2024 | 2024-03-31 | −160.29% | −3.65 pp |
| 2023 | 2023-03-31 | −156.64% | −124.85 pp |
| 2022 | 2022-03-31 | −31.80% | −29.71 pp |
| 2021 | 2021-03-31 | −2.09% | — |
Burcon NutraScience quarterly return on equity
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2025-09-30 | −192.84% | — |
| Q1 2026 | 2025-06-30 | −65.93% | — |
| Q4 2025 | 2025-03-31 | −12.82% | — |
Burcon NutraScience return on equity trends
Over the last five fiscal years, Burcon NutraScience's return on equity decreased from −2.09% to −2,488.94%, a change of −2486.86 percentage points. The latest reported quarter, Q2 2026, shows −192.84%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burcon NutraScience source filings ↗